Article 1
2,2-Dibromo-2-cyanoacetamide (DBNPA) is approved as an active substance for use in biocidal products of product-type 6, subject to the conditions set out in the Annex.
Commission Implementing Regulation (EU) 2025/937 of 21 May 2025 approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 6 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
2,2-Dibromo-2-cyanoacetamide (DBNPA) is approved as an active substance for use in biocidal products of product-type 6, subject to the conditions set out in the Annex.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance ( 1 ) Date of approval Expiry date of approval Product type Specific conditions DBNPA IUPAC name: 2,2-Dibromo-2-cyanoacetamide EC No: 233-539-7 CAS No: 10222-01-2 Minimum purity of the active substance evaluated: 98,0 % 1 November 2026 31 October 2031 6 2,2-Dibromo-2-cyanoacetamide (‘DBNPA’) is a candidate for substitution in accordance with Article 10(1), points (a) and (e), of Regulation (EU) No 528/2012. The authorisation of biocidal products using DBNPA as an active substance is subject to the following conditions: (a) the product assessment pays particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level assessment of the active substance; (b) pursuant to point 10 of Annex VI to Regulation (EU) No 528/2012, the product assessment includes an evaluation as to whether the condition set out in Article 5(2), point (c), of Regulation (EU) No 528/2012 is satisfied; (c) products may only be authorised for use in Member States where the condition set out in Article 5(2), point (c), of Regulation (EU) No 528/2012 is satisfied; (d) products may only be authorised for the short-term preservation by industrial users of: i) mineral slurries and of other additives (e.g., starch, fillers, binders, defoamers, polymer solutions, barrier products, coatings, pigments) used in paper production; ii) paints and coatings (including pigments, varnishes and inks) and of raw materials (e.g., starch, fillers, binders, defoamers, pigments) used for paints and coatings production; iii) polymer dispersions (e.g., polymer dispersions used in adhesives, non-woven fabrics, carpet making compounds, premix plasters, wall fillers); (e) the product assessment pays particular attention to industrial users; (f) for products that may lead to residues in food or feed, Member States’ competent authorities assess whether new maximum residue levels or maximum residue limits need to be set or the existing maximum residue levels or maximum residue limits need to be amended in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council ( 2 ) or Regulation (EC) No 396/2005 of the European Parliament and of the Council ( 3 ) , and any appropriate risk mitigation measures are taken to ensure that such maximum residue levels or maximum residue limits are not exceeded; (g) Member States’ competent authorities specify in the summary of the biocidal product characteristics of a biocidal product containing DBNPA the relevant instructions for use and precautions to be indicated on the label of the treated articles under Article 58(3), second subparagraph, point (e), of Regulation (EU) No 528/2012. The placing on the market of treated articles treated with or incorporating DBNPA is subject to the following conditions: (a) treated articles treated with or intentionally incorporating DBNPA may be placed on the market only for use as: i) mineral slurries and other additives used in paper production; ii) paints and coatings (including pigments, varnishes and inks) and raw materials used for their production; iii) polymer dispersions; (b) DBNPA has been used in the treated articles referred in point (a) only to ensure a short-term preservation; (c) the person responsible for the placing on the market of a treated article treated with or incorporating DBNPA ensures that the label of that treated article provides the information listed in Article 58(3), second subparagraph, of Regulation (EU) No 528/2012. ( 1 ) The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product made available on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance. ( 2 ) Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council ( OJ L 152, 16.6.2009, p. 11 , ELI: http://data.europa.eu/eli/reg/2009/470/oj ). ( 3 ) Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC ( OJ L 70, 16.3.2005, p. 1 , ELI: http://data.europa.eu/eli/reg/2005/396/oj ).
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.